Cas 174722-31-7 rituximab monoclonal For Non Hodgkin'S Lymphoma
Cas 174722-31-7 rituximab monoclonal For Non Hodgkin'S Lymphoma
| Product name:Rituximab | Purity:99% min |
| CAS NO:174722-31-7 | Solubility:Soluble in DMSO |
| Molecular Formula:C6416H9874N1688O1987S44 | Package:Package according to customer requirements |
| Molecular Weight:143859.7 g/mol | Storage:Store at -20℃ |
Rituximab is a medication used to treat certain autoimmune diseases and types of cancer.It is used for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris and myasthenia gravis.It is given by slow injection into a vein.
Related Prodcuts:
Pembrolimumab; Secukinumab; Infliximab; Ramucirumab; Ipilimumab; Atezolizumab; Daratumumab; Dulaglutide; Adalimumab; Bevacizumab; Aflibercept; Cetuximab
[1]. Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50.
[2]. Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54.
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.